March 10, 2015

Teva Pharmaceuticals will sell its Sellersville, Penn., facility to G&W Labs. According to Teva, the move supports its mission of streamlining operations by reducing excess manufacturing capacity.

March 9, 2015

Apple on Monday better enabled medical research with the launch of open source software framework ResearchKit. 

March 2, 2015

Mylan on Friday announced the successful completion of the acquisition of Abbott Laboratories' non-U.S. developed markets specialty and branded generics business.

March 2, 2015

The implementation of an e-prescribing mandate in New York hits a snag as state legislators agree to a delay.

March 2, 2015

The FDA is expected to issue new guidance on biosimilars labeling and generic opioids before the end of year, according to a report by the Regulatory Affairs Professional Society.

February 27, 2015

Camber Pharmaceuticals' latest generic drug launch is used to treat pulmonary hypertension.

February 27, 2015

Epic Pharma on Friday launched two generics: a schedule II pain reliever and a calcium channel blocker. 

February 26, 2015

Congress introdues legislation to protect FDA user fees from sequestration. 

February 26, 2015

A survey found that chronic disease patients who use digital technology to manage their disease state feel "healthier."

 

February 26, 2015

Greenstone, a subsidiary of Pfizer, announced the introduction of trandolapril/verapamil hydrochloride extended-release tablets to its line of generic pharmaceutical products. 

 

February 25, 2015

In 10 years, the percentage of opioid analgesic users who used an opioid analgesic stronger than morphine increased from 17% to 37%, NCHS reported Wednesday. 

February 24, 2015

The Food and Drug Administration is looking into enabling holders of abbreviated new drug applications to unilaterally update their generic drug product labels prior to any branded drug change. 

February 24, 2015

Lupin will bring to market a generic version of Lumigan solution, the company announced. 

February 24, 2015

Mylan has been appointed as the exclusive India distributor of Sovaldi (sofosbuvir 400mg tablets) and Harvoni (ledipasvir 90mg/sofosbuvir 400 mg tablets) for the treatment of chronic hepatitis C, by Gilead Sciences. 

February 24, 2015

Researchers found that switching glaucoma patients to a generic prostaglandin analogue improved adherence. 

 

February 24, 2015

According to the latest Walgreens Flu Index, flu activity is no longer picking up across the West Coast and in Texas. 

February 23, 2015

A centralized notification system for immunization reminders would significantly improve childhood immunization rates, according to a study pubished in  JAMA Pediatrics

February 20, 2015

Actavis on Friday gained approval for a generic version of Reckitt Benckiser's Subutex, indicated for the treatment of opioid dependence.

February 20, 2015

The recently introduced Ensuring Patient Access and Effective Drug Enforcement Act of 2015 receives support from the National Association of Chain Drug Stores.

February 19, 2015

Surescripts on Thursday released a step-by-step video guide targeting both small providers and health systems to enable adoption of electronic prescribing of controlled substances.

February 18, 2015

Actavis on Wednesday announced that it will adopt a new corporate name — Allergan — following the anticipated, successful completion of the acquisition of Allergan.

February 18, 2015

Lupin Pharmaceuticals on Wednesday launched the InspiraChamber Anti-Static Valved Holding Chamber for respiratory medicines under a strategic licensing agreement with InspiRX.

February 18, 2015

PatientsLikeMe and Walgreens are trying to make it easier for people to understand how the medications they take may affect them.

 

February 17, 2015

Lupin and Celon Pharma announced Tuesday that they have entered into a definitive agreement under which the companies will jointly develop a fluticasone/salmeterol dry powder inhaler product which is a generic version of GlaxoSmithKline's Advair Diskus.